These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8439642

  • 1. Calcium polycarbophil compared with placebo in irritable bowel syndrome.
    Toskes PP, Connery KL, Ritchey TW.
    Aliment Pharmacol Ther; 1993 Feb; 7(1):87-92. PubMed ID: 8439642
    [Abstract] [Full Text] [Related]

  • 2. [Physicochemical and pharmacological characteristic and clinical efficacy of an anti-irritable bowel syndrome agent, polycarbophil calcium (Polyful)].
    Iwanaga Y.
    Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):185-90. PubMed ID: 11915521
    [Abstract] [Full Text] [Related]

  • 3. Colonic transit, bowel movements, stool form, and abdominal pain in irritable bowel syndrome by treatments with calcium polycarbophil.
    Chiba T, Kudara N, Sato M, Chishima R, Abiko Y, Inomata M, Orii S, Suzuki K.
    Hepatogastroenterology; 2005 Mar; 52(65):1416-20. PubMed ID: 16201086
    [Abstract] [Full Text] [Related]

  • 4. Serial changes in cytokine expression in irritable bowel syndrome patients following treatment with calcium polycarbophil.
    Chiba T, Sato K, Toya Y, Endo K, Abiko Y, Kasugai S, Saito S, Oana S, Kudara N, Endo M, Suzuki K.
    Hepatogastroenterology; 2011 Mar; 58(110-111):1527-30. PubMed ID: 21940313
    [Abstract] [Full Text] [Related]

  • 5. [Effect of polycarbophil Ca on IBS].
    Mine T.
    Nihon Rinsho; 2006 Aug; 64(8):1483-6. PubMed ID: 16898617
    [Abstract] [Full Text] [Related]

  • 6. Calcium polycarbophil improves constipation in non-traumatic spinal cord disorders.
    Sakakibara R, Yamaguchi T, Uchiyama T, Liu Z, Yamamoto T, Ito T, Odaka T, Hattori T.
    Clin Auton Res; 2006 Aug; 16(4):289-92. PubMed ID: 16810464
    [Abstract] [Full Text] [Related]

  • 7. Laxative and anti-diarrheal activity of polycarbophil in mice and rats.
    Saito T, Mizutani F, Iwanaga Y, Morikawa K, Kato H.
    Jpn J Pharmacol; 2002 Jun; 89(2):133-41. PubMed ID: 12120755
    [Abstract] [Full Text] [Related]

  • 8. Calcium polycarbophil (Mitrolan).
    Med Lett Drugs Ther; 1981 May 29; 23(11):52. PubMed ID: 7015097
    [No Abstract] [Full Text] [Related]

  • 9. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.
    Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR.
    Aliment Pharmacol Ther; 2003 Apr 01; 17(7):895-904. PubMed ID: 12656692
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology, toxicology, clinical efficacy, and adverse effects of calcium polycarbophil, an enteral hydrosorptive agent.
    Danhof IE.
    Pharmacotherapy; 1982 Apr 01; 2(1):18-28. PubMed ID: 6765389
    [Abstract] [Full Text] [Related]

  • 11. Effect of calcium polycarbophil on bowel function after restorative proctocolectomy for ulcerative colitis: a randomized controlled trial.
    Shibata C, Funayama Y, Fukushima K, Takahashi K, Ogawa H, Haneda S, Watanabe K, Kudoh K, Kohyama A, Hayashi K, Sasaki I.
    Dig Dis Sci; 2007 Jun 01; 52(6):1423-6. PubMed ID: 17394081
    [Abstract] [Full Text] [Related]

  • 12. The intestinal ecosystem in chronic functional constipation.
    Zoppi G, Cinquetti M, Luciano A, Benini A, Muner A, Bertazzoni Minelli E.
    Acta Paediatr; 1998 Aug 01; 87(8):836-41. PubMed ID: 9736230
    [Abstract] [Full Text] [Related]

  • 13. [Calcium polycarbophil in clinical practice. The therapy of constipation].
    Pallotta N, Rubinetto MP, Zaccaro C, Gizzi G, Villani V, Barbara L.
    Minerva Gastroenterol Dietol; 1993 Dec 01; 39(4):175-8. PubMed ID: 8161616
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.
    Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974
    [Abstract] [Full Text] [Related]

  • 17. Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449].
    Dancey CP, Attree EA, Brown KF.
    Nutr J; 2006 Jun 08; 5():16. PubMed ID: 16762076
    [Abstract] [Full Text] [Related]

  • 18. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome.
    Schütze K, Brandstätter G, Dragosics B, Judmaier G, Hentschel E.
    Aliment Pharmacol Ther; 1997 Apr 08; 11(2):387-94. PubMed ID: 9146780
    [Abstract] [Full Text] [Related]

  • 19. Double blind study of ispaghula in irritable bowel syndrome.
    Prior A, Whorwell PJ.
    Gut; 1987 Nov 08; 28(11):1510-3. PubMed ID: 3322956
    [Abstract] [Full Text] [Related]

  • 20. A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula.
    Sallon S, Ben-Arye E, Davidson R, Shapiro H, Ginsberg G, Ligumsky M.
    Digestion; 2002 Nov 08; 65(3):161-71. PubMed ID: 12138321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.